JAMES REGGIO: Open Payments
NPI 1932120557 · SANTA CRUZ, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$424 in 4 payments from 4 companies in 2025. Trend: 2023 $372 · 2024 $450 · 2025 $424
Food & beverage: $424
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 1 | $137 |
| Neurocrine BioSciences, Inc. | 1 | $127 |
| Axsome Therapeutics, Inc. | 1 | $125 |
| Alkermes, Inc. | 1 | $35 |
Products named: INVEGA SUSTENNA, INGREZZA, Auvelity, LYBALVI.
Industry payments across CA — which companies pay providers there.
